Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005829 | cytosol | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9AU75
Term | Name | Level | Count |
---|---|---|---|
GO:0000096 | sulfur amino acid metabolic process | 4 | 9 |
GO:0006082 | organic acid metabolic process | 3 | 9 |
GO:0006520 | amino acid metabolic process | 3 | 9 |
GO:0006555 | methionine metabolic process | 5 | 9 |
GO:0006575 | cellular modified amino acid metabolic process | 3 | 9 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 9 |
GO:0006730 | one-carbon metabolic process | 3 | 9 |
GO:0006760 | folic acid-containing compound metabolic process | 4 | 9 |
GO:0006790 | sulfur compound metabolic process | 3 | 9 |
GO:0006807 | nitrogen compound metabolic process | 2 | 9 |
GO:0008152 | metabolic process | 1 | 9 |
GO:0009066 | aspartate family amino acid metabolic process | 5 | 9 |
GO:0009987 | cellular process | 1 | 9 |
GO:0019752 | carboxylic acid metabolic process | 5 | 9 |
GO:0035999 | tetrahydrofolate interconversion | 4 | 9 |
GO:0042558 | pteridine-containing compound metabolic process | 4 | 9 |
GO:0043436 | oxoacid metabolic process | 4 | 9 |
GO:0044237 | cellular metabolic process | 2 | 9 |
GO:0044238 | primary metabolic process | 2 | 9 |
GO:0044281 | small molecule metabolic process | 2 | 9 |
GO:0046483 | heterocycle metabolic process | 3 | 9 |
GO:0046653 | tetrahydrofolate metabolic process | 5 | 9 |
GO:0071704 | organic substance metabolic process | 2 | 9 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 9 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 9 |
GO:1901605 | alpha-amino acid metabolic process | 4 | 9 |
GO:0000097 | sulfur amino acid biosynthetic process | 5 | 1 |
GO:0008652 | amino acid biosynthetic process | 4 | 1 |
GO:0009058 | biosynthetic process | 2 | 1 |
GO:0009067 | aspartate family amino acid biosynthetic process | 6 | 1 |
GO:0009086 | methionine biosynthetic process | 6 | 1 |
GO:0016053 | organic acid biosynthetic process | 4 | 1 |
GO:0044249 | cellular biosynthetic process | 3 | 1 |
GO:0044272 | sulfur compound biosynthetic process | 4 | 1 |
GO:0044283 | small molecule biosynthetic process | 3 | 1 |
GO:0046394 | carboxylic acid biosynthetic process | 5 | 1 |
GO:1901566 | organonitrogen compound biosynthetic process | 4 | 1 |
GO:1901576 | organic substance biosynthetic process | 3 | 1 |
GO:1901607 | alpha-amino acid biosynthetic process | 5 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 9 |
GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity | 5 | 9 |
GO:0016491 | oxidoreductase activity | 2 | 9 |
GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors | 3 | 9 |
GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor | 4 | 9 |
GO:0000166 | nucleotide binding | 3 | 1 |
GO:0005488 | binding | 1 | 1 |
GO:0036094 | small molecule binding | 2 | 1 |
GO:0043167 | ion binding | 2 | 1 |
GO:0043168 | anion binding | 3 | 1 |
GO:0050660 | flavin adenine dinucleotide binding | 4 | 1 |
GO:0071949 | FAD binding | 5 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901265 | nucleoside phosphate binding | 3 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 183 | 187 | PF00656 | 0.318 |
CLV_C14_Caspase3-7 | 256 | 260 | PF00656 | 0.274 |
CLV_PCSK_KEX2_1 | 208 | 210 | PF00082 | 0.274 |
CLV_PCSK_PC1ET2_1 | 208 | 210 | PF00082 | 0.274 |
CLV_PCSK_SKI1_1 | 108 | 112 | PF00082 | 0.315 |
CLV_PCSK_SKI1_1 | 205 | 209 | PF00082 | 0.310 |
CLV_PCSK_SKI1_1 | 299 | 303 | PF00082 | 0.329 |
CLV_PCSK_SKI1_1 | 96 | 100 | PF00082 | 0.290 |
DEG_APCC_KENBOX_2 | 254 | 258 | PF00400 | 0.318 |
DOC_CKS1_1 | 77 | 82 | PF01111 | 0.318 |
DOC_MAPK_gen_1 | 205 | 215 | PF00069 | 0.264 |
DOC_MAPK_MEF2A_6 | 208 | 217 | PF00069 | 0.298 |
DOC_MAPK_MEF2A_6 | 45 | 53 | PF00069 | 0.227 |
DOC_PP4_FxxP_1 | 23 | 26 | PF00568 | 0.187 |
DOC_USP7_MATH_1 | 187 | 191 | PF00917 | 0.318 |
DOC_USP7_UBL2_3 | 92 | 96 | PF12436 | 0.209 |
DOC_WW_Pin1_4 | 44 | 49 | PF00397 | 0.337 |
DOC_WW_Pin1_4 | 76 | 81 | PF00397 | 0.318 |
DOC_WW_Pin1_4 | 87 | 92 | PF00397 | 0.216 |
LIG_14-3-3_CanoR_1 | 234 | 239 | PF00244 | 0.347 |
LIG_14-3-3_CanoR_1 | 60 | 68 | PF00244 | 0.258 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.398 |
LIG_BRCT_BRCA1_1 | 19 | 23 | PF00533 | 0.187 |
LIG_BRCT_BRCA1_1 | 46 | 50 | PF00533 | 0.287 |
LIG_EH1_1 | 104 | 112 | PF00400 | 0.318 |
LIG_FHA_1 | 102 | 108 | PF00498 | 0.404 |
LIG_FHA_1 | 214 | 220 | PF00498 | 0.347 |
LIG_FHA_1 | 295 | 301 | PF00498 | 0.224 |
LIG_FHA_1 | 63 | 69 | PF00498 | 0.292 |
LIG_FHA_2 | 141 | 147 | PF00498 | 0.347 |
LIG_FHA_2 | 166 | 172 | PF00498 | 0.212 |
LIG_FHA_2 | 17 | 23 | PF00498 | 0.347 |
LIG_Integrin_RGD_1 | 114 | 116 | PF01839 | 0.253 |
LIG_LIR_Apic_2 | 20 | 26 | PF02991 | 0.187 |
LIG_LIR_Gen_1 | 201 | 207 | PF02991 | 0.287 |
LIG_LIR_Gen_1 | 282 | 291 | PF02991 | 0.318 |
LIG_LIR_Gen_1 | 47 | 57 | PF02991 | 0.271 |
LIG_LIR_Nem_3 | 142 | 147 | PF02991 | 0.298 |
LIG_LIR_Nem_3 | 19 | 24 | PF02991 | 0.310 |
LIG_LIR_Nem_3 | 201 | 206 | PF02991 | 0.291 |
LIG_LIR_Nem_3 | 227 | 232 | PF02991 | 0.331 |
LIG_LIR_Nem_3 | 282 | 286 | PF02991 | 0.318 |
LIG_LIR_Nem_3 | 297 | 301 | PF02991 | 0.178 |
LIG_LIR_Nem_3 | 47 | 53 | PF02991 | 0.314 |
LIG_Pex14_1 | 17 | 21 | PF04695 | 0.347 |
LIG_SH2_STAP1 | 198 | 202 | PF00017 | 0.268 |
LIG_SH2_STAT5 | 139 | 142 | PF00017 | 0.265 |
LIG_SH2_STAT5 | 147 | 150 | PF00017 | 0.238 |
LIG_SH2_STAT5 | 18 | 21 | PF00017 | 0.258 |
LIG_SH2_STAT5 | 180 | 183 | PF00017 | 0.253 |
LIG_SH2_STAT5 | 203 | 206 | PF00017 | 0.359 |
LIG_SH2_STAT5 | 289 | 292 | PF00017 | 0.290 |
LIG_SH3_3 | 35 | 41 | PF00018 | 0.347 |
LIG_SH3_3 | 74 | 80 | PF00018 | 0.371 |
LIG_TYR_ITIM | 281 | 286 | PF00017 | 0.318 |
LIG_WRC_WIRS_1 | 40 | 45 | PF05994 | 0.161 |
LIG_WW_3 | 24 | 28 | PF00397 | 0.253 |
MOD_CDK_SPK_2 | 87 | 92 | PF00069 | 0.274 |
MOD_CK1_1 | 242 | 248 | PF00069 | 0.413 |
MOD_CK1_1 | 294 | 300 | PF00069 | 0.264 |
MOD_CK1_1 | 62 | 68 | PF00069 | 0.301 |
MOD_CK2_1 | 16 | 22 | PF00069 | 0.287 |
MOD_GlcNHglycan | 278 | 281 | PF01048 | 0.318 |
MOD_GlcNHglycan | 293 | 296 | PF01048 | 0.178 |
MOD_GSK3_1 | 187 | 194 | PF00069 | 0.375 |
MOD_GSK3_1 | 234 | 241 | PF00069 | 0.283 |
MOD_GSK3_1 | 287 | 294 | PF00069 | 0.347 |
MOD_GSK3_1 | 58 | 65 | PF00069 | 0.285 |
MOD_GSK3_1 | 83 | 90 | PF00069 | 0.334 |
MOD_N-GLC_1 | 291 | 296 | PF02516 | 0.347 |
MOD_NEK2_1 | 148 | 153 | PF00069 | 0.327 |
MOD_NEK2_1 | 191 | 196 | PF00069 | 0.274 |
MOD_NEK2_1 | 213 | 218 | PF00069 | 0.198 |
MOD_NEK2_1 | 238 | 243 | PF00069 | 0.253 |
MOD_NEK2_1 | 291 | 296 | PF00069 | 0.375 |
MOD_NEK2_1 | 51 | 56 | PF00069 | 0.309 |
MOD_NEK2_1 | 83 | 88 | PF00069 | 0.253 |
MOD_NEK2_1 | 99 | 104 | PF00069 | 0.253 |
MOD_NEK2_2 | 198 | 203 | PF00069 | 0.347 |
MOD_PIKK_1 | 191 | 197 | PF00454 | 0.253 |
MOD_PKA_2 | 276 | 282 | PF00069 | 0.321 |
MOD_PKA_2 | 59 | 65 | PF00069 | 0.304 |
MOD_Plk_1 | 198 | 204 | PF00069 | 0.347 |
MOD_Plk_1 | 51 | 57 | PF00069 | 0.287 |
MOD_Plk_1 | 62 | 68 | PF00069 | 0.253 |
MOD_Plk_4 | 187 | 193 | PF00069 | 0.420 |
MOD_Plk_4 | 198 | 204 | PF00069 | 0.360 |
MOD_Plk_4 | 39 | 45 | PF00069 | 0.216 |
MOD_ProDKin_1 | 44 | 50 | PF00069 | 0.337 |
MOD_ProDKin_1 | 76 | 82 | PF00069 | 0.318 |
MOD_ProDKin_1 | 87 | 93 | PF00069 | 0.216 |
TRG_ENDOCYTIC_2 | 147 | 150 | PF00928 | 0.327 |
TRG_ENDOCYTIC_2 | 203 | 206 | PF00928 | 0.373 |
TRG_ENDOCYTIC_2 | 229 | 232 | PF00928 | 0.287 |
TRG_ENDOCYTIC_2 | 283 | 286 | PF00928 | 0.318 |
TRG_Pf-PMV_PEXEL_1 | 138 | 142 | PF00026 | 0.355 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IKP8 | Leptomonas seymouri | 67% | 100% |
A0A0S4IQL6 | Bodo saltans | 53% | 99% |
A0A1X0NM13 | Trypanosomatidae | 55% | 100% |
A0A3Q8IJZ9 | Leishmania donovani | 91% | 100% |
A4HQF9 | Leishmania braziliensis | 86% | 100% |
A4IC95 | Leishmania infantum | 91% | 100% |
O54235 | Streptomyces lividans | 33% | 100% |
O67422 | Aquifex aeolicus (strain VF5) | 36% | 100% |
P0AEZ1 | Escherichia coli (strain K12) | 33% | 100% |
P0AEZ2 | Shigella flexneri | 33% | 100% |
P11003 | Salmonella typhimurium (strain LT2 / SGSC1412 / ATCC 700720) | 31% | 100% |
P45208 | Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) | 33% | 100% |
P57154 | Buchnera aphidicola subsp. Acyrthosiphon pisum (strain APS) | 31% | 100% |
P71319 | Pectobacterium carotovorum subsp. carotovorum | 32% | 100% |
Q4Q0B9 | Leishmania major | 90% | 100% |
Q89B13 | Buchnera aphidicola subsp. Baizongia pistaciae (strain Bp) | 30% | 100% |
Q8KA62 | Buchnera aphidicola subsp. Schizaphis graminum (strain Sg) | 30% | 100% |
Q9JZQ3 | Neisseria meningitidis serogroup B (strain MC58) | 33% | 100% |